Published in Infection on May 16, 1991
Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet (1992) 3.52
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A (1991) 2.74
Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia (2010) 2.04
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol (2001) 1.70
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol (2009) 1.55
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst (1990) 1.49
An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med (1992) 1.48
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (1993) 1.43
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 1.33
A genetic history of Italy. Ann Hum Genet (1988) 1.33
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet (1997) 1.31
Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect (2010) 1.29
Cytokine network and acute primary HIV-1 infection. AIDS (1993) 1.28
Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg (1997) 1.22
Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect (2009) 1.16
Intestinal localization of anisakiasis manifested as acute abdomen. Clin Microbiol Infect (2003) 1.13
Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol (1996) 1.07
Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant (2008) 1.05
Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React (1987) 1.05
Ultrasound diagnosis of pneumothorax. Radiol Med (2006) 1.03
Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes (2001) 1.03
Cultural competence in oncology: where do we stand? Ann Oncol (2009) 1.03
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol (1993) 1.02
Modelling the spatial spread of H7N1 avian influenza virus among poultry farms in Italy. Epidemics (2010) 1.01
D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus. Diabetologia (2005) 1.00
Oligella urethralis urosepsis. Clin Infect Dis (1993) 0.98
The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun (2009) 0.98
Convergence of a structured metapopulation model to Levins's model. J Math Biol (2004) 0.97
Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia (2006) 0.97
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. J Clin Oncol (1999) 0.97
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia (2008) 0.97
Nosocomial infections in pediatric cardiac surgery, Italy. Infect Control Hosp Epidemiol (2001) 0.96
14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes. Tissue Antigens (2007) 0.94
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study. J Clin Oncol (1999) 0.94
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol (1998) 0.91
Variability of the Brachmann-de Lange syndrome. Am J Med Genet (1993) 0.90
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes (1992) 0.89
Interaction of human plasma fibronectin with viral proteins of human immunodeficiency virus. FEMS Immunol Med Microbiol (1994) 0.89
Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle. FASEB J (1999) 0.89
Severe and complicated Falciparum malaria in Italian travelers. J Travel Med (1998) 0.88
On the formulation of epidemic models (an appraisal of Kermack and McKendrick). J Biol Dyn (2012) 0.87
Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS (2000) 0.87
Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. J Autoimmun (1992) 0.87
Induction of interferon by nonreplicating single-stranded RNA virus. Proc Soc Exp Biol Med (1974) 0.87
Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival. Radiol Med (2012) 0.87
Scenarios of diffusion and control of an influenza pandemic in Italy. Epidemiol Infect (2008) 0.86
Legionella micdadei prosthetic valve endocarditis. Infection (1994) 0.86
A functional CD40 receptor is expressed in pancreatic beta cells. Diabetologia (2005) 0.86
Telling the truth to the patient with cancer. A cross-cultural dialogue. Ann N Y Acad Sci (1997) 0.86
Meningoencephalitis caused by Toxoplasma gondii diagnosed by isolation from cerebrospinal fluid in an HIV-positive patient. Scand J Infect Dis (1993) 0.85
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer. Semin Oncol (1993) 0.85
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies. Virchows Arch A Pathol Anat Histopathol (1992) 0.85
Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors. J Med Chem (1994) 0.85
An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy. Eur J Epidemiol (1992) 0.84
Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis (1997) 0.84
Interferon-gamma levels in serum and bronchoalveolar lavage fluid of mice infected with Bordetella pertussis. J Infect Dis (1993) 0.84
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet (1997) 0.83
Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1. Cell Biochem Funct (1999) 0.83
Adhesion of Proteus species to various cell types. Eur J Clin Microbiol (1983) 0.83
Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. Dig Dis Sci (1999) 0.83
Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family. Gut (2005) 0.82
Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma. Br J Cancer (1991) 0.82
Apoptotic DNA fragmentation, and its in vitro prevention by nicotinamide, in lymphocytes from HIV-1-seropositive patients and in HIV-1-infected MT-4 cells. Cell Biochem Funct (1997) 0.82
Prediction and prevention of type I diabetes. Transplant Proc (1994) 0.82
Decreased interferon response to polyinosinic-polycytidylic acid in rabbits immunized against the inducer. Proc Soc Exp Biol Med (1972) 0.82
Pathogen coexistence induced by density-dependent host mortality. J Theor Biol (1995) 0.82
Clinical findings associated with Borrelia burgdorferi infection in the dog. Vet Res Commun (2003) 0.82
Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm (2000) 0.82
Validation of ICTERUS, a knowledge-based expert system for Jaundice diagnosis. Methods Inf Med (2000) 0.81
Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele. J Autoimmun (1996) 0.81
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology (1994) 0.81
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. Am J Transplant (2012) 0.80
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma. Br J Haematol (1992) 0.80
The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients. J Autoimmun (1990) 0.80
Phytosterol compounds having antiviral efficacy. Panminerva Med (1997) 0.80
Gametic association of HSP70-1 promoter region alleles and their inclusion in extended HLA haplotypes. Tissue Antigens (1993) 0.80
Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology (1999) 0.80
[Differences of capacity of human erythrocytes of newborn infants and adults and trypsin-treated erythrocytes to bind rubella virus hemagglutinin]. G Batteriol Virol Immunol (1978) 0.80
Image-guided microwave ablation of hepatic tumours: preliminary experience. Radiol Med (2011) 0.80
Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis. J Infect Dis (1986) 0.80
Prevalence and predictors of blood-brain barrier damage in the HAART era. J Neurovirol (2014) 0.79
Levels of circulating fibronectin receptor in adult and pediatric patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (1994) 0.79
Evidence of circulating interferon-gamma in newly diagnosed diabetic children. Acta Paediatr Scand (1984) 0.79
Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases. J Hepatol (1999) 0.79
Cyclic AMP levels in lung and spleen tissue of mice treated with pertussis toxin. Microbiologica (1989) 0.79
Establishment of cell cultures from hydatid cysts of Echinococcus granulosus. Int J Parasitol (1988) 0.79
Growth of Candida albicans in a minimal synthetic medium without biotin. Mycopathologia (1987) 0.79
Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling. Biosci Rep (2007) 0.79
Effects of clenbuterol on haemocoagulation process in calves. J Vet Med A Physiol Pathol Clin Med (2005) 0.78